top of page
Image by SJ Objio
VAPPL.png
Virus Evasion MHC

VAPPL

Viral Antigen Processing & Presentation Lab

Exploring HLA class I antigen processing and prevention in viral immune detection and evasion

News

Our Research

MHC class I peptide selection

MHC class I molecules (HLA in humans) are essential for orchestrating immune responses to tumours and pathogen-infected cells. They do this by presenting protein fragments (peptides) from pathogen and tumour proteins at the cell surface for surveillance by immune cells. When CD8+ T cells detect a foreign (viral) peptide presented by MHC-I, they will proceed to lysing the target cell.

To evade immune detection, viruses have evolved strategies to manipulate MHC-I molecules. Alternatively, viruses can interfere with other proteins of the antigen processing and pathway that are involved in the generation, selection and loading of peptides on MHC-I.

​

With our research, we aim to better understand the MHC-I pathway in virus infections to i) gain a better understanding of immune detection of virus-infected cells and ii) to explore novel strategies by which viruses evade MHC-I pathway proteins.​ This has important translational potential given the importance of MHC molecules in infectious disease, cancer, and autoimmunity. 

MEET THE TEAM

Protein vaccine

Public Engagement

We are incredibly excited about connecting with the community and motivating school children to pursue careers in science.

mRNA vaccine

Publications

Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C Molecules

Altenburg AF#,  Morley JL, Bauer J,  Walz JS,  Boyle LH#

​

Wellcome Open Res. 2024.

doi: 10.12688/wellcomeopenres.20738.1

Scientist Working in Laboratory
The Royal Society
Wellcome Trust

University of Cambridge

Department of Pathology

Tennis Court Road

Cambridge CB2 1QP

United Kingdom

afa34 [at] cam.ac.uk

+44 (0) 1223 330949

bottom of page